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Effectiveness of transcranial direct current stimulation preceding 
cognitive behavioural management for chronic low back pain: 
sham controlled double blinded randomised controlled trial
Kerstin Luedtke,1 Alison Rushton,2 Christine Wright,2 Tim Jürgens,1 Astrid Polzer,1 
Gerd Mueller,3 Arne May1 
ABSTRACT
ObjeCtive
To evaluate the effectiveness of transcranial direct 
current stimulation alone and in combination with 
cognitive behavioural management in patients with 
non-specific chronic low back pain.
Design
Double blind parallel group randomised controlled trial 
with six months’ follow-up conducted May 2011-March 
2013. Participants, physiotherapists, assessors, and 
analyses were blinded to group allocation.
setting
Interdisciplinary chronic pain centre.
PartiCiPants
135 participants with non-specific chronic low back 
pain >12 weeks were recruited from 225 patients 
assessed for eligibility.
interventiOn
Participants were randomised to receive anodal (20 
minutes to motor cortex at 2 mA) or sham transcranial 
direct current stimulation (identical electrode position, 
stimulator switched off after 30 seconds) for five 
consecutive days immediately before cognitive 
behavioural management (four week multidisciplinary 
programme of 80 hours).
Main OutCOMes Measures
Two primary outcome measures of pain intensity 
(0-100 visual analogue scale) and disability (Oswestry 
disability index) were evaluated at two primary 
endpoints after stimulation and after cognitive 
behavioural management.
results
Analyses of covariance with baseline values (pain or 
disability) as covariates showed that transcranial 
direct current stimulation was ineffective for the 
reduction of pain (difference between groups on 
visual analogue scale 1 mm (99% confidence interval 
−8.69 mm to 6.3 mm; P=0.68)) and disability 
(difference between groups 1 point (−1.73 to 1.98; 
P=0.86)) and did not influence the outcome of 
cognitive behavioural management (difference 
between group 3 mm (−10.32 mm to 6.73 mm); 
P=0.58; difference between groups on Oswestry 
disability index 0 point (−2.45 to 2.62); P=0.92). 
The stimulation was well tolerated with minimal 
transitory side effects.
COnClusiOns
This results of this trial on the effectiveness of 
transcranial direct current stimulation for the reduction 
of pain and disability do not support its clinical use for 
managing non-specific chronic low back pain.
trial registratiOn
Current controlled trials ISRCTN89874874.
Introduction
Low back pain is one of the most prevalent and expen-
sive musculoskeletal conditions.1  It is generally 
benign,2  with 74-89% patients recovering after three to 
six months,3  though about 9-28% develop chronic 
pain.4-7  Non-specific chronic low back pain does not 
have a defined source,7 8  and the pathogenesis is not 
fully understood. In the absence of a peripheral pathol-
ogy, central sensitisation has been hypothesised to 
explain the development and maintenance of non- 
specific chronic low back pain.9 10  Main mechanisms 
are an increased release of excitatory neurotransmitters 
at spinal level, influencing pain perception via the spi-
nothalamic pathway and altered top down pain control 
from the brain.11 12
International guidelines recommend multimodal 
cognitive behavioural therapy programmes, defined as 
structured interventions designed to modify dysfunc-
tional thinking and behaviour,13  as the most effective 
available intervention for reduction of pain and disabil-
ity.8 14-16  A recent systematic review identified moderate 
evidence for the short term effectiveness of cognitive 
behavioural interventions.17  The pooled effect size for 
pain reduction compared with other active inter-
ventions, however, was low (12 mm on a 0-100 mm 
visual analogue scale). Adjunct approaches that mod-
ulate excitability of the central nervous system have 
been proposed to enhance the effects of cognitive 
WhAT IS AlReAdy knoWn on ThIS TopIC
Numerous small studies have suggested that transcranial direct current stimulation 
can reduce chronic pain
Until now evidence from appropriately powered randomised controlled trials has 
been lacking
Systematic reviews and meta-analyses indicated a small beneficial effect but also 
highlighted the high risk of bias of existing trials
WhAT ThIS STudy AddS
This is the first adequately powered trial, with low risk of bias, to evaluate 
transcranial direct current stimulation for pain reduction
Transcranial direct current stimulation over the motor cortex has no benefit for the 
reduction of pain and disability in patients with non-specific chronic low back pain
Furthermore, transcranial direct current stimulation applied immediately before a 
cognitive behavioural group intervention does not influence the outcome of the 
intervention
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behavioural management on non-specific chronic low 
back pain.18-20
Transcranial direct current stimulation is a non-inva-
sive technique to electrically stimulate the brain. It can 
be applied to different target areas on the skull by 
attachment of sponge electrodes soaked in saline solu-
tion. It is hypothesised that this influences cortical 
excitability by inducing positively or negatively charged 
currents through the skull,21  thereby modulating a 
widespread neural network of areas associated with 
pain processing including the thalamic nuclei, limbic 
system, brainstem nuclei, and spinal cord.22  Pain 
reducing effects of transcranial direct current stimula-
tion are attributed to modulation of the endogenous 
opioid system,23  emotional appraisal of pain,24  and 
descending pain inhibition.23-25
Systematic reviews and meta-analyses on the effective-
ness of anodal transcranial direct current stimulation 
reported a small pain reducing effect with stimulation of 
the motor cortex.26 27  The overall level of evidence, how-
ever, was low to very low26 27  because of an overall 
unclear or high risk of bias and inadequate sample sizes 
in all included trials. Recent research reported that pain 
reduction after traditional interventions was enhanced 
by the application of transcranial direct current stimula-
tion as an adjuvant intervention—that is, as a priming 
technique to repetitive transcranial magnetic stimula-
tion,28  combined with transcutaneus electrical nerve 
stimulation29  or with a multidisciplinary programme.30
We evaluated the effectiveness of transcranial direct 
current stimulation on non-specific chronic low back 
pain and investigated its use as an adjunct intervention 
before cognitive behavioural management.
Methods
study design and participants
This double blind parallel group randomised controlled 
trial was conducted in Germany. Trial design and its 
reporting followed the internationally recognised rec-
ommendations published by the CONSORT group,31  the 
International Conference on Harmonisation of Techni-
cal Requirements for Registration of Pharmaceuticals 
for Human Use,32  and the World Medical Association’s 
Declaration of Helsinki.33
Participants were adults aged 18-65 with non-specific 
chronic low back pain persisting for more than 12 weeks 
as defined in the European guidelines8 who met the eli-
gibility criteria for cognitive behavioural management 
at a back pain clinic in Germany. All participants pre-
sented with a minimum of 15 mm on a 0-100 visual ana-
logue scale for pain or 8 points on the Oswestry 
disability index. Eligibility for the cognitive behavioural 
management programme required the patient to under-
stand and speak German. Patients had to be motivated 
to return to work and had to be physically fit enough to 
tolerate a four week physical training programme. An 
orthopaedic consultant, a psychologist, and a physio-
therapist confirmed a participant’s eligibility for cognitive 
behavioural management by following a standard screen-
ing procedure. Participants were excluded if they pre-
sented with other chronic pain syndromes, neurological 
disease, or psychiatric disease; had had spinal surgery 
in the previous six months; were pregnant or trying to 
become pregnant; or misused alcohol, drugs, or pre-
scription drugs.
randomisation and blinding
Randomisation to anodal or sham stimulation was 
conducted in permuted blocks of 20 to allow for equal 
numbers in each study arm at various time points34-37 
and stratified for baseline pain intensity.38 We ran-
domised 160 stimulation codes (80 triggering active 
stimulation, 80 triggering sham stimulation) by cus-
tom written software into two separate lists for low 
(20-50 mm) and high (51-100 mm) pain intensity at 
baseline on a visual analogue scale. An independent 
researcher created the randomisation lists. To achieve 
allocation concealment the recruiter provided partici-
pants with the next unused stimulation code from the 
randomised lists. The recruiter had no access to the 
randomisation list. Blinding of participants and the 
treating physiotherapist was achieved by using a sham 
paradigm identical to the anodal stimulation proce-
dure except that the direct current stimulator automat-
ically switched off after 30 seconds after slowly 
reducing the stimulation intensity (5 second fade out). 
Stimulation mode (anodal/sham) was preprogrammed 
with five digit stimulation codes that triggered the 
active or sham procedure. The machine display con-
tinued to indicate the time and the impedance in the 
same manner for both procedures. Because of the ini-
tial brief stimulation period, associated skin sensa-
tion, and identical machine display, this method has 
previously been regarded as a reliable placebo condi-
tion for double blind trial designs.39-41  More recent 
debate, however, questioned the reliability of partici-
pant and assessor blinding with this sham paradigm.42 
We therefore evaluated the success of blinding by ask-
ing participants after each stimulation session which 
type of stimulation they believed they had received. 
Additionally, the assessor recorded which stimulation 
type she believed the participant had received. To 
evaluate whether participants and investigator could 
guess the stimulation type better than would be 
expected by chance, we determined the κ coefficient of 
agreement for each day of stimulation.42 43 Blinding 
during data analysis was achieved by labelling partic-
ipants “group A” and “group B” (performed by an 
independent researcher).
interventions
Transcranial direct current stimulation
Participants received 20 minutes of anodal or sham 
stimulation over the left motor cortex with an inten-
sity of 2 mA on five consecutive days. We chose this 
stimulation paradigm based on results from our sys-
tematic review, which identified it as the most effec-
tive in chronic pain trials with the lowest risk of bias.27 
Transcranial direct current stimulation was produced 
by a small battery driven stimulator device and 
applied to the skull via saline solution (0.9%) soaked 
sponge electrodes (7×5 cm=35 cm2). The anode was 
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placed over the left motor cortex, while the cathode 
was placed supraorbitally on the contralateral side, 
and both were held in place by elastic bandages. The 
electricity was slowly increased to 2 mA at the begin-
ning of the stimulation (eight seconds fade in) and 
slowly decreased at the end of the stimulation (eight 
seconds fade out) to reduce skin sensations under-
neath the electrodes.44  Single pulse transcranial mag-
netic stimulation (Magstim Company, Dyfed, UK) was 
applied to accurately determine the location of the 
left motor cortex (abductor digiti minimi) with a stan-
dard protocol.45 46
Cognitive behavioural management
Immediately after the stimulation period all partici-
pants started a cognitive behavioural management pro-
gramme. A maximum of eight patients per group 
received physically challenging sessions, including car-
diovascular exercises, machine assisted muscle 
strength training, specific muscle stabilisation exer-
cises for the trunk muscles, and work hardening 
 sessions, as well as educational sessions on the neuro-
physiology of pain, pain coping strategies, and relax-
ation classes. Patients attended five hours daily for four 
weeks as outpatients. An interdisciplinary team of 
orthopaedic consultants, physiotherapists, psycholo-
gists, and sports scientists delivered the cognitive 
behavioural management programme.
Outcome measures
Transcranial direct current stimulation and cognitive 
behavioural management have different suggested 
roles within the management of non-specific chronic 
low back pain. Transcranial direct current stimulation 
directly targets pain processing areas within the brain, 
aiming to reduce pain intensity; this was therefore 
essential as a primary outcome measure. Cognitive 
behavioural management targets disability, cognitions, 
and beliefs associated with chronic pain and other psy-
chosocial aspects of the pain experience and might not 
necessarily result in a reduction of pain intensity.47-49 To 
deal with the research objective of the combined effect 
of transcranial direct current stimulation and cognitive 
behavioural management, we therefore also selected 
disability (Oswestry disability index) as a primary out-
come measure.
The initiative on methods, measurement, and pain 
assessment in clinical trials defined the following out-
come domains as important for chronic pain trials: 
pain, physical functioning, emotional functioning, par-
ticipants’ ratings of improvement and satisfaction, 
symptoms and adverse events, and participants’ dispo-
sition.50  We also selected the following secondary out-
come measures according to their evidence base for 
evaluating non-specific chronic low back pain and their 
measurement properties: Funktionsfragebogen Han-
nover (Hannover functional ability questionnaire),51 
“bothersomeness,”52  RAND 36-item health survey,53 
fear avoidance beliefs questionnaire,54  hospital anxiety 
and depression score,55  and patient perceived satisfac-
tory improvement.56
Participants were assessed immediately before the 
first session of transcranial direct current stimulation 
(baseline), 24 hours after the final stimulation (primary 
endpoint 1), on the last day of cognitive behavioural 
management (primary endpoint 2), and four weeks, 12 
weeks, and 24 weeks after cognitive behavioural man-
agement to observe longer term treatment effects (fig 1).
Based on the two primary outcome measures and the 
two primary endpoints, we calculated the sample size 
at an α level of 0.0125 (90% power).57 58  Based on rec-
ommendations for a minimum clinically relevant 
change of 15 mm on a 0-100 mm visual analogue scale 
for pain59 and 8 points on the Oswestry disability 
index,60  and allowing for a dropout rate of 12% after 
transcranial direct current stimulation61  and a further 
16% after the cognitive behavioural management,62  we 
required 135 participants. The calculated effect sizes 
were 0.79 for visual analogue scale and 0.75 for Oswestry 
disability index and were regarded as medium to large63 
(G*Power Version 3.1.2).
To document any observed side effects, after each 
stimulation session participants were required to com-
plete a standardised questionnaire routinely used for 
transcranial direct current stimulation trials.45 64 All 
procedures were tested in a feasibility trial conducted 
before the main data collection phase.
Data analysis
We collected participants’ characteristics and baseline 
values for primary and secondary outcome measures to 
allow comparisons between groups at baseline.
Primary analyses were conducted at an α level of 
P<0.0125 as described for the sample size calculation.65 
To evaluate the effectiveness of transcranial direct cur-
rent stimulation, we fitted a general linear model for 
each of the two primary outcome measures (visual ana-
logue scale, Oswestry disability index) at each of the two 
primary endpoints (after stimulation and after cognitive 
behavioural management) using values after the inter-
vention as the dependent variable and values before the 
intervention as covariates (analysis of covariance 
Screening and randomisation
Baseline assessment
Anodal tDCS Sham tDCS 5 days
Time
4 weeks
Assessment aer stimulation
CBT
Assessment aer CBT 
Follow-up assessments
4 weeks, 12 weeks, 24 weeks
Fig 1 | Flowchart for trial of effectiveness of anodal or sham 
transcranial direct current stimulation (tDCs) alone and 
before cognitive behavioural management (Cbt) for 
patients with chronic low back pain
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(ANCOVA)).66 67 We reported results as F values (with 
degrees of freedom) and P values as well as 99% confi-
dence intervals for differences between groups with 
Sidak adjustment for multiple comparisons.68
We conducted secondary analyses at an exploratory 
level and did not require further adjustment of the α 
level for multiple testing.65  To evaluate the intervention 
effect on the primary outcome measures over time, we 
fitted a separate multilevel model for pain and disability, 
including all assessment time points. All secondary out-
come measures were entered into the statistical model in 
a stepwise manner (forward approach) and removed if 
not significant.69 These factors, as well as group (anodal, 
sham), were added to the model as fixed effect factors 
while time, time2, and time3 were entered as random fac-
tors to model a non-linear trend over time.70
To explore the effect of anodal stimulation compared 
with sham stimulation on each of the secondary out-
come measures at the primary endpoints after stimula-
tion and after cognitive behavioural management, we 
used analysis of covariance using baseline values as 
covariates. The secondary outcome measures were fur-
ther evaluated by building a multilevel model with 
time, time,2 and time3 as random factors and group 
(active, sham) as a fixed effect factor. We conducted 
Bonferroni corrected post hoc t tests if we identified a 
significant interaction of group by time for any second-
ary outcome measure.68 All analyses were performed 
with SPSS 18 for Apple Macintosh (SPSS, Chicago, IL).
Results
Recruitment took place from May 2011 to March 2013. All 
consecutive patients who were waiting for the cognitive 
behavioural management programme (n=255) were con-
tacted by telephone and assessed for eligibility to recruit 
the required 135 participants. Of 232 eligible patients, 97 
declined to participate because of the additional time 
and travel required for the extra five visits to the back 
pain clinic for the stimulation. Figure 2 shows the num-
bers of participants analysed at each time point .71
Table 1 shows the baseline characteristics by inter-
vention group , which indicate representativeness of 
participants in comparison with internationally pub-
lished trials evaluating cognitive behavioural manage-
ment interventions in non-specific chronic low back 
pain.62 72-74  Table 2 presents baseline data on primary 
and secondary outcome measures.
None of the participants switched group. Missing 
data at the two primary endpoints were balanced across 
groups. The total amount of missing data was less than 
10% after stimulation and a further 3% (pain) and 10% 
(disability) after cognitive behavioural management. 
This amount was within the anticipated dropout rate 
for the sample size calculation. Reasons provided for 
discontinuing the trial were not based on clinical data 
but on additional time and travel. Data were therefore 
considered to be missing at random. Following pub-
lished recommendations, data met the two main princi-
ples for intention to treat analysis.75 76
There were no significant differences between groups 
for pain and Oswestry disability index at the two pri-
mary endpoints after stimulation and after cognitive 
behavioural management. Table 3  and figs 3  and 4 
show mean values and results of statistical tests.
When we looked at the effects on pain and Oswestry 
disability index over time, we found no significant 
interactions between the factors group and time using a 
multilevel model analysis on visual analogue scale for 
pain (95% confidence interval for the estimates of 
group*time as a fixed effect was −0.84 to 0.20; P=0.23) or 
Oswestry disability index (−0.16 to 0.11; P=0.72) (table 4). 
Stepwise building of the multilevel models for pain 
Allocated to sham stimulation (n=68)
Received allocated intervention (n=68)
Allocated to anodal stimulation (n=67)
Received allocated intervention (n=67)
Analysis 1 (VAS n=60; ODI n=61)
Excluded from analysis (n=0)
Lost to follow-up 1 (missing data)
  (VAS n=5; ODI n=4)
Discontinued intervention (skin reaction,
  conflicting appointments) (n=2)
Lost to follow-up 1 (missing data)
  (VAS n=4; ODI n=5)
Discontinued intervention (surgery, conflicting
  appointments) (n=2)
Analysis 1 (VAS n=62; ODI n=61)
Excluded from analysis (n=0)
Assessed for eligibility (n=255)
Randomised (n=135)
Analysis 2 (VAS n=60; ODI n=53)
Excluded from analysis (n=0)
Lost to follow-up 2 (missing data)
  (VAS n=7; ODI n=9)
Discontinued intervention (n=0)
Lost to follow-up 2 (missing data)
  (VAS n=7; ODI n=6)
Discontinued intervention (surgery, acute
  sciatica, influenza) (n=3)
Analysis 2 (VAS n=58; ODI n=54)
Excluded from analysis (n=0)
Excluded (n=120):
  Did not meet inclusion criteria (n=23):
    Pain <15 VAS and ODI <8 at baseline (n=12)
    Surgery <6 months ago (n=11)
  Declined to participate (n=97)
Aer stimulation
Aer CBT
Analysis 3 (VAS n=54; ODI n=55)
Excluded from analysis (n=0)
Lost to follow-up 3 (missing data)
  (VAS n=13; ODI n=12)
Lost to follow-up 3 (missing data)
  (VAS n=12; ODI n=12)
Analysis 3 (VAS n=56; ODI n=56)
Excluded from analysis (n=0)
4 weeks aer
Analysis 4 (VAS n=53; ODI n=52)
Excluded from analysis (n=0)
Lost to follow-up 4 (missing data)
  (VAS n=14; ODI n=15)
Lost to follow-up 4 (missing data)
  (VAS n=20; ODI n=19)
Analysis 4 (VAS n=48; ODI n=49)
Excluded from analysis (n=0)
12 weeks aer
Analysis 5 (VAS n=47; ODI n=48)
Excluded from analysis (n=0)
Lost to follow-up 5 (missing data)
  (VAS n=20; ODI n=19)
Lost to follow-up 5 (missing data)
  (VAS n=26; ODI n=26)
Analysis 5 (VAS n=42; ODI n=42)
Excluded from analysis (n=0)
24 weeks aer
Fig 2 | Flow of patient inclusion and numbers of participants available for analysis at each 
prespecified time point for both primary outcome measures (Oswestry disability index 
(ODi) and visual analogue scale for pain (vas)) in trial of effectiveness of anodal or sham 
transcranial direct current stimulation (tDCs) before cognitive behavioural management 
(Cbt) for patients with chronic low back pain
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and Oswestry disability index are reported in appendi-
ces 1 and 2.
The analysis of secondary outcome measures at the 
primary endpoints (table 5) and throughout the trial 
showed results similar to pain and Oswestry disability 
index: both groups improved slightly during the stimu-
lation period and significantly after the cognitive 
behavioural management (within group changes). Mul-
tilevel models for all secondary outcome measures 
showed that there were no significant differences 
between groups at any time point.
The success of blinding was based on ratings from 
587 participants (one rating per participant per day of 
stimulation). Three quarters of ratings (n=442) indi-
cated that participants believed they had received 
anodal stimulation. As agreement was poor to slight, 
participants were effectively blinded throughout the 
trial (table 6 ). The κ coefficient for correctly guessed 
treatment groups was κ=0.103. This result is translated 
as slight agreement and thereby indicating effective 
investigator blinding.77
discussion
Five days of anodal transcranial direct current stimula-
tion compared with sham stimulation did not result in a 
reduction of the perceived intensity or level of disability 
in non-specific chronic low back pain. Trial results did 
not support the pain reducing effect of transcranial 
direct current stimulation on chronic pain as reported 
by previously published trials or the small combined 
effect size identified in systematic reviews and 
meta-analyses.26 27 Furthermore, transcranial direct cur-
rent stimulation preceding cognitive behavioural man-
agement did not influence the reduction of pain and 
disability levels after the behavioural management.
This trial was specifically designed to evaluate the 
effectiveness of transcranial direct current stimulation 
on pain and disability in non-specific chronic low back 
pain and the adjuvant effects of transcranial direct cur-
rent stimulation on cognitive behavioural management. 
The study population was carefully selected with clear 
inclusion/exclusion criteria to achieve a level of homo-
geneity that reflected the typical participants of a cogni-
tive behavioural management programme. This allows 
us to generalise our results to other cognitive 
behavioural management settings.
As critiqued in our systematic review,27  all previous 
published trials have been limited by small sample sizes. 
Sample size calculations (if reported) were based on tran-
scranial magnetic stimulation studies with large effect 
sizes and small standard deviations61  or on previous pub-
lications of equally underpowered studies.29  Small sam-
ple sizes and risk of bias issues identified by systematic 
reviews26 27 reduce the confidence in such reported effect 
sizes for pain reduction after transcranial direct current 
stimulation. The current trial is the only trial to date on 
transcranial direct current stimulation that included a 
sufficient number of participants to show an effect on 
pain, based on a valid calculation of sample size.
results in context
Furthermore, this is the first randomised controlled trial 
to exclusively investigate the effect of transcranial 
direct current stimulation on non-specific chronic low 
back pain. Two previous trials on transcranial direct 
current stimulation for the reduction of chronic pain 
included some participants with chronic low back pain. 
Antal and colleagues investigated a mixed population 
of 23 patients with chronic pain that included eight with 
chronic low back pain.78  Results indicated a significant 
pain reducing effect in the group that received anodal 
stimulation. Only five patients with chronic low back 
pain, however, received both anodal and sham stimula-
tion. As these patients were not analysed separately, we 
could not distinguish the effect of anodal transcranial 
direct current stimulation on chronic low back pain 
from the overall effect.78  A second exploratory study 
focused on the reduction of non-specific chronic low 
back pain and found no effect of transcranial direct cur-
rent stimulation over sham stimulation.79 The study 
included eight participants and followed an interrupted 
time series design in which participants received sham 
stimulation until a randomly allocated day, when the 
stimulation changed to anodal mode. This method 
resulted in a minimum of three and a maximum of 15 
stimulation sessions per patient. This design did not 
allow the evaluation of a specific stimulation paradigm, 
table 1 | Demographic and clinical characteristics of participants with back pain at 
baseline according to randomisation in trial of effectiveness of anodal or sham 
transcranial direct current stimulation (tDCs). Figures are numbers (percentage) of 
participants unless stated otherwise
intervention group
anodal (n=67) sham (n=68)
Women 33 (49) 30 (44)
Age at study entry (years)*:
 Mean (SD) 45 (9) 44 (10) 
 Range 26-64 27-62
First onset of back pain (months ago)*:
 Mean (SD) 98 (106) 93 (125) 
 Range 6-600 6-384
This episode of back pain (months)*:
 Mean (SD) 23 (49) 19 (29) 
 Range 6-156 6-240
Drug treatment
Drugs for pain:
 NSAIDS 43 (64) 34 (50)
 Week opioids 6 (9) 4 (6)
 Strong opioids 7 (10) 6 (9)
Adjuvant drug treatments:
 Antidepressants 3 (4) 3 (4)
 Muscle relaxants 1 (1) 1 (1)
 Anticonvulsives 3 (4) 0 (0)
 Glucocorticoids 1 (1) 0 (0)
Drug treatments taken for other conditions:
 Cardiovascular 9 (13) 9 (13)
 Asthma 3 (4) 2 (3)
 Thyroid 1 (1) 1 (1)
 Restless legs 1 (1) 0 (0)
 Hormone replacement 3 (4) 1 (1)
 Malaria 1 (1) 0 (0)
NSAIDS=non-steroid anti-inflammatory drugs. 
*No significant difference (P<0.05) between two groups at baseline.
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especially as stimulation was applied with varying gaps 
between sessions of up to six days. The small sample 
size was a further limitation; hence the effectiveness of 
transcranial direct current stimulation on non-specific 
chronic low back pain could not be evaluated.
Five days of anodal stimulation did not result in a sig-
nificant reduction of the disability associated with 
non-specific chronic low back pain. Two trials on tran-
scranial direct current stimulation for the reduction of 
pain evaluated disability with the Roland Morris dis-
ability questionnaire as a secondary outcome. In a 
crossover trial in seven participants with chronic pelvic 
pain, Fenton and colleagues found a reduction of 0.83 
out of 24 points that was significant but not clinically 
relevant.80  A second trial in eight participants resulted 
in a reduction of 0.5 points in the sham group and 1.7 
points in the anodal stimulation group.79  Results were 
not analysed for significance between groups, and rec-
ommended minimum clinically relevant levels of 
change in the Roland Morris disability questionnaire of 
4-5 points59 60 were not met.
One previous trial applied transcranial direct current 
stimulation in combination with a multidisciplinary 
intervention for the reduction of fibromyalgia pain.30 
Twenty three patients were randomly assigned to 
table 3 | Mean (sD) values and results from analysis of covariance (anCOva) for visual analogue scale (vas) for pain and Oswestry disability index 
(ODi) after stimulation and after cognitive behavioural management with 99% confidence intervals for differences between groups 
Outcome 
measure
after stimulation after Cbt
Mean (sD) 
anodal 
Mean (sD) 
sham 
Mean difference between 
groups (99% Ci) P value
Mean (sD) 
anodal 
Mean (sD) 
sham 
Mean difference between 
groups (99% Ci) P value
VAS (mm) 42 (24), n=60 41 (23), n=62 1 (−8.69 to 6.3) 0.68 26 (23), n=60 23 (18), n=58 3 (−10.32 to 6.73) 0.58
ODI (points) 15 (7), n=61 14 (6), n=61 1 (−1.73 to 1.98) 0.86 7 (6), n=53 7 (5), n=54 0 (−2.45 to 2.62) 0.92
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Fig 3 | box plot of visual analogue scale (vas) pain values at 
baseline and primary endpoints (after anodal or sham 
transcranial direct current stimulation (tDCs) and after 
cognitive behavioural management (Cbt)) for patients with 
chronic low back pain
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Fig 4 | box plot of Oswestry disability index (ODi) values at 
baseline and primary endpoints (after anodal or sham 
transcranial direct current stimulation (tDCs) and after 
cognitive behavioural management (Cbt)) for patients with 
chronic low back pain
table 2 | baseline data on primary and secondary outcome measures by intervention 
group in trial of effectiveness of anodal or sham transcranial direct current stimulation 
(tDCs) preceding cognitive behavioural management (Cbt) for patients with chronic low 
back pain*
intervention group
anodal (n=67) sham (n=68)
Primary outcome measures
Mean (SD) VAS (0-100 mm) 48 (21) 48 (18)
 Range 15-89 15-84
Mean (SD) ODI (0-50 points) 17 (6) 15 (5)
 Range 8-32 8-29
secondary outcome measures 
Mean (SD) FABQ physical activity (0-24 points) 14 (4) 15 (7)
 Range 7-20 2-24
Mean (SD) FABQ work (0-42 points) 21 (11) 23 (10)
 Range 2-42 9-40
Mean (SD) FfBH (12-36 points) 22 (4) 21 (4)
 Range 12, 29 12, 33
Mean (SD) HADS anxiety (0-21 points) 7 (4) 6 (4)
 Range 0-15 0-18
Mean (SD) HADS depression (0-21 points) 6 (4) 6 (4)
 Range 0-15 0-14
RAND-36 (0-100%):
 Mean (SD) physical functioning 54 (19) 58 (23)
  Range 0-90 10-100
 Mean (SD) role limitations from physical health 19 (28) 15 (28)
  Range 0-100 0-100
 Mean (SD) pain 31 (16) 32 (12)
  Range 0-74 0-52
 Mean (SD) general health 50 (17) 54 (19)
  Range 15-92 20-100
 Mean (SD) energy / fatigue 38 (19) 44 (18)
  Range 0-85 10-85
 Mean (SD) social functioning 56 (26) 61 (26)
  Range 0-100 0-100
 Mean (SD) role limitations from emotional problems 51 (43) 49 (43)
  Range 0-100 0-100
 Mean (SD) emotional wellbeing 58 (19) 60 (18)
  Range 20-96 24-92
Median (range) bothersomeness (0-4 points) 3 (2-4) 3 (2-4)
 Interquartile range 3-4 3-4
FABQ=fear avoidance beliefs questionnaire; FfBH=Funktionsfragebogen Hannover; HADS=hospital anxiety and 
depression scale; ODI=Oswestry disability index; RAND-36=RAND 36-item health survey; VAS=visual analogue 
scale for pain.
*At P<0.05 there were no significant differences between groups at baseline.
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weekly active and sham stimulation sessions for 10 
weeks during a multidisciplinary intervention. No effect 
for pain was found, and disability was not measured. 
Compared with sham stimulation, however, anodal 
stimulation was associated with a significant effect on the 
SF-36 subscale for pain. This effect should be interpreted 
with caution as the sample size calculation was based on 
a large effect size of 3 cm on a 0-10 cm visual analogue 
scale and standard deviations of 2.5. Furthermore, two 
outcome measures were presented (but not defined a pri-
ori) in the results section at an α level of 0.05 and a power 
of 80%. No adjustments for multiple testing were made.
Neurophysiological explanations for the lack of a 
treatment effect can only be hypothesised. Top down 
pain inhibition is the most described working mecha-
nism for transcranial direct current stimulation.81 82  It 
is also known as central pain modulation and relies on 
the concept that altered cortical activity leads to a 
descending cascade of events consequently resulting 
in pain relief.83  The primary motor cortex is the origin 
of the descending corticothalamic pathway. Polania 
and colleagues found an increased functional coupling 
of the motor cortex and the thalamus after anodal tran-
scranial direct current stimulation over the primary 
motor cortex84  and further evidence suggested a 
spreading of electrical currents to subcortical areas 
distant from the stimulation site.85 86  Modulation of the 
H reflex in the quadriceps muscle indicated that the 
effects of transcranial direct current stimulation 
descended as far down as the leg via the spinal path-
way in healthy participants.87  But evidence that these 
remote effects lead to pain reduction relied on studies 
with controversial results using experimental pain or 
pain thresholds.45 64 88-92 In summary, there is  sufficient 
table 4 | Primary outcome measures at 4, 12, and 24 weeks’ follow-up after cognitive behavioural management (Cbt) and results of multilevel model 
analysis
Outcome measure and group
Mean (sD) score by time after Cbt 95% Ci for estimates of 
group*time
P value for group*time 
interaction4 weeks 12 weeks 24 weeks
visual analogue scale for pain
Sham 23 (23), n=56 22 (22), n=48 22 (21), n=42
−0.84 to 0.20 0.23
Anodal 26 (26), n=54 27 (26), n=53 29 (26), n=47
Oswestry disability index
Sham 7 (6), n=56 6 (6), n=49 7 (6), n=42
−0.16 to 0.11 0.72
Anodal 8 (7), n=56 9 (7), n=52 9 (7), n=48
table 5 | Mean (sD) values and results from analysis of covariance (anCOva) for all secondary outcome measures after stimulation and after cognitive 
behavioural management (Cbt)
after stimulation after Cbt
Mean (sD) 
anodal 
Mean (sD) 
sham 
95% Ci for differences 
between groups P values
Mean (sD) 
anodal
Mean (sD) 
sham
95% Ci for differences 
between groups P values
FABQ:
 Physical activity 15 (4), n=62 15 (4), n=61 −3.24 to 3.14 0.98 9 (4), n=54 10 (7), n=55 −4.75 to 5.32 0.91
 Work 21 (12), n=62 21 (12), n=61 −5.92 to 4.74 0.82 16 (9), n=54 14 (11), n=55 −8.47 to 5.96 0.72
FfBH 21 (4), n=62 20 (5), n=61 −0.70 to 1.39 0.51 16 (4), n=54 16 (4), n=55 −1.58 to1.11 0.73
HADS:
 Anxiety 7 (4), n=59 6 (4), n=58 −0.95 to 0.51 0.56 5 (4), n=52 4 (3), n=52 −1.10 to 0.88 0.83
 Depression 6 (4), n=59 6 (4), n=57 −1.10 to 0.69 0.65 4 (4), n=52 4 (3), n=51 −0.85 to 1.15 0.77
Bothersomeness 3 (1), n=61 3 (1), n=61 −0.18 to 0.30 0.63 2 (1), n=54 2 (1), n=55 −0.47 to 0.30 0.67
PPSI 1 (1), n=61 2 (1), n=61 −0.29 to 0.55 0.54 3 (1), n=54 3 (1), n=55 −0.57 to 0.21 0.36
RAND-36:
 Physical activity 57 (19), n=62 62 (21), n=61 −2.64 to 8.45 0.30 81 (19), n=58 85 (18), n=59 −3.51 to 8.64 0.41
  Role limitations from 
physical health
23 (32), n=61 21 (32), n=61 −5.90 to 11.53 0.52 53 (46), n=53 59 (44), n=54 −7.09 to 23.71 0.29
 Pain 33 (13), n=61 33 (14), n=61 −3.12 to 4.35 0.77 49 (18), n=53 53 (17), n=55 −1.44 to 11.31 0.13
 General health 52 (19), n=58 55 (19), n=61 −5.52 to 4.37 0.82 60 (20), n=53 63 (21), n=55 −5.36 to 5.54 0.97
 Energy/fatigue 43 (20), n=59 47 (18), n=61 −7.02 to 2.87 0.41 56 (16), n=54 58 (19), n=54 −4.59 to 6.87 0.69
 Social functioning 59 (26), n=62 64 (28), n=59 −3.82 to 7.24 0.54 77 (22), n=54 75 (22), n=53 −13.25 to 0.88 0.09
  Role limitations from 
emotional problems
47 (45), n=62 52 (46), n=61 −3.62 to 21.13 0.16 70 (42), n=54 78 (37), n=54 −5.78 to 19.53 0.28
 Emotional wellbeing 60 (19), n=60 63 (17), n=60 −1.83 to 5.83 0.30 73 (18), n=53 73 (16), n=53 −7.89 to 2.03 0.24
FABQ=fear avoidance beliefs questionnaire; FfBH=Funktionsfragebogen Hannover; HADS=hospital anxiety and depression scale; PPSI=patient perceived satisfactory improvement.
table 6 | effectiveness of blinding of participants in trial of effectiveness of anodal or sham transcranial direct current stimulation preceding cognitive 
behavioural management for patients with chronic low back pain
Day 1 (n=112) Day 2 (n=120) Day 3 (n=124) Day 4 (n=118) Day 5 (n=120)
Agreement between guessed and received stimulation κ =0.111 κ =0.000 κ =−0.014 κ =−0.007 κ =−0.120
Interpretation (Landis and Koch77) Slight agreement Slight agreement Poor agreement Poor agreement Poor agreement
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evidence to support a reliable cortical and  subcortical 
neurophysiological response to transcranial direct cur-
rent stimulation but alterations in pain perception 
were absent or inconsistent.
limitations
A limitation of this trial is that it was conducted at one 
study centre. The sample of patients with non-specific 
chronic low back pain, however, is representative for 
international cognitive behavioural management set-
tings regarding baseline demographic data and base-
line clinical variables.62 72 73 74  A further limitation could 
be that transcranial direct current stimulation was 
applied before cognitive behavioural management. We 
cannot exclude a beneficial effect of transcranial direct 
current stimulation on non-specific chronic low back 
pain applied during cognitive behavioural manage-
ment, although Riberto and colleagues evaluated tran-
scranial direct current stimulation applied during a 
multidisciplinary intervention and found no effect on 
pain in patients with fibromyalgia.30
In conclusion, we have shown that transcranial 
direct current stimulation alone or in combination with 
cognitive behavioural management is inefficient for the 
reduction of pain and disability in patients with 
non-specific chronic low back pain.
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Appendix 1: Stepwise building of mixed model for 
visual analogue scale over all time points
Appendix 2: Stepwise building of mixed model for 
Oswestry disability index over all time points
